Company ProfilePremium

Beneficial Insectary Inc.

Company Profile Analysis

Ticker: FLOB.BR

ESOMAR 23 Corporate BadgeISO Certifications Badge
Beneficial Insectary Inc. - Company showcase

Year Founded & Workforce

1986

Beneficial Insectary Inc. logo

Beneficial Insectary Inc. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Beneficial Insectary Inc. Overview

Beneficial Insectary is a Redding, California producer of beneficial insects, predatory mites and entomopathogenic nematodes for biological pest control and integrated pest management (IPM). It began as a fly parasite producer serving animal husbandry, then expanded into crop protection and was described in 2020 as North America's largest independent producer of beneficial insects and mites. Since late 2020 it has been part of Biobest, the horticulture biocontrol and pollination arm of BioFirst Group, itself controlled by Brussels-listed Floridienne. It keeps its own brand, its "force" product line and a distributor-led sales model, and it added Northeast US reach by buying its distributor Sierra Biological in 2023. Its strategic role inside the group is local US production: live organisms have short shelf lives, so domestic rearing is a reliability advantage. Its financial scale is undisclosed.

Company's own description. There is no annual report. Trade press releases describe Beneficial Insectary as a US biocontrol industry pioneer and North America's top producer of beneficial insects and mites, originally a small family farm and now part of BioFirst Group, distributing across North America (Hortibiz, July 2024).

Independent characterization. The company is a specialist manufacturer of living biological control agents. It rears arthropods and nematodes, packages them in carriers or release systems, and ships them chilled on short lead times.

Revenue model: product sales. No subscription or licensing revenue is disclosed. The mix by product is not disclosed.

Value chain position: producer, selling largely through distributors. The 2020 release called its distribution model "highly complementary" to Biobest USA's, and Sierra Biological "mainly" distributed its products before being acquired.

Customers and end-markets: greenhouse vegetable and ornamental growers, nurseries, cannabis growers (named as a target segment in the Sierra release), open-field and orchard users of Trichogramma and lacewings, and livestock, dairy, poultry and equine operations for fly control. Homeowner sales also occur (CB Insights news excerpt).

Strategy

No strategy document is published by Beneficial Insectary. Themes below come from press statements.

Autonomy within the group: In 2020 the Biobest CEO said both companies would keep their identity, operate autonomously and serve their own customer bases, with focus on operational synergies for reliable local supply. Noorlander repeated the value of this independence in 2023.

Local production: The stated goal is a North American production base combining Redding with Biobest facilities in Canada and Mexico.

Distribution consolidation: The Sierra Biological purchase secured the Northeast channel.

Cannabis segment: Sierra's technologies were to be used in the offering to cannabis growers.

Commercial build-out: The 2024 Sales Director appointment aims to make the brand the preferred US biocontrol supplier.

Group initiatives (last 24 months): acquisition of Ecoation's Crop-Scanner and OKO 2 technology (August 2025) for automated IPM scouting, and extension of Plant Products distribution across the United States (April 2026, headline only).

Financial targets and guidance: not publicly disclosed.

Products & Services

Product names are from the insectary.com catalog (accessed October 2026). Organism identities are analyst inferences from product naming conventions and should be confirmed against product labels. Launch years, pack sizes and prices are not publicly disclosed.

The site also offers IPM guidance and technical resources. Sierra Biological contributes in-house nematode production and technologies for cannabis pests (Greenhouse Grower, 2023).

Product Portfolio

ProductOrganism (inferred)TypeTarget pests

APHIDIUSforce C

Aphidius colemani

Parasitic wasp

Aphids

APHIDIUSforce E

Aphidius ervi

Parasitic wasp

Aphids

APHIDIUSforce CE

A. colemani and A. ervi blend

Parasitic wasp mix

Aphids

APHIDIUSforce M

Aphidius matricariae

Parasitic wasp

Aphids

APHIDIUSforce Mix

Multi-species Aphidius blend

Parasitic wasp mix

Aphids

APHIDOLETESforce

Aphidoletes aphidimyza

Predatory midge

Aphids

CHRYSOforce R

Chrysoperla rufilabris

Green lacewing

Aphids, mealybugs, whitefly, thrips, caterpillar eggs

AMBLYforce A

Amblyseius andersoni

Predatory mite

Spider and other mites

AMBLYforce C

Neoseiulus cucumeris

Predatory mite

Thrips, mites

AMBLYforce S

Amblyseius swirskii

Predatory mite

Whitefly, thrips, mites

CALIforce

Neoseiulus californicus

Predatory mite

Spider mites

FELTIELLAforce

Feltiella acarisuga

Predatory midge

Spider mites

PERSIMILISforce

Phytoseiulus persimilis

Predatory mite

Two-spotted spider mite

STRATIOforce

Stratiolaelaps scimitus

Soil predatory mite

Fungus gnats, thrips pupae, soil pests

DALOTIAforce

Dalotia coriaria

Rove beetle

Fungus gnats, shore flies, soil pests

NEMAforce HB

Heterorhabditis bacteriophora

Nematode

Soil pests

NEMAforce SC

Steinernema carpocapsae

Nematode

Shore flies, soil pests

NEMAforce SF

Steinernema feltiae

Nematode

Fungus gnats, soil pests

NEMAforce SK

Steinernema kraussei

Nematode

Soil pests

TRICHOforce B

Trichogramma brassicae

Egg parasitoid

Caterpillars and moths

TRICHOforce PL

Trichogramma platneri

Egg parasitoid

Caterpillars and moths

TRICHOforce M

Trichogramma minutum

Egg parasitoid

Caterpillars and moths

TRICHOforce Mix

Trichogramma blend

Egg parasitoid mix

Caterpillars and moths

CRYPTOforce

Cryptolaemus montrouzieri

Predatory beetle

Mealybugs

ERETforce

Eretmocerus eremicus

Parasitic wasp

Whitefly

ENCARSIAforce

Encarsia formosa

Parasitic wasp

Whitefly

ENCAR/ERETforce

Encarsia and Eretmocerus blend

Parasitic wasp mix

Whitefly

ORIUSforce

Orius insidiosus

Predatory bug

Thrips

FlyForce

Fly parasites (species not stated)

Parasitic wasps

Filth flies in livestock settings

Wheast

Not stated

Supplemental food for beneficials

—

NUTRIforce

Not stated

Supplemental food for beneficials

—

Universal Release Boxes

—

Release hardware

—

Financial Narrative

Beneficial Insectary Inc. standalone: revenue, gross profit, operating income, EBITDA, net income, EPS, dividends, balance sheet, cash flow and all ratios are not publicly disclosed. No estimates are offered.

Parent context: Floridienne S.A. consolidated (EUR M)

Sources: Floridienne Annual Report 2023, Rapport annuel 2024, FY2025 results release (31 March 2026). Share percentages are analyst calculations.

Commentary. The Life Sciences Division grew at roughly 29% a year from FY2021 to FY2025 (analyst calculation on a rounded FY2021 base), driven mainly by acquisitions. FY2023 was weak: Floridienne called it a disappointing year for Biobest and booked EUR 5.9 M of non-recurring Biotrop acquisition costs. FY2024 EBITDA more than doubled with Biotrop consolidated and strong greenhouse-market performance. FY2025 turnover rose 6.2% but EBITDA fell to EUR 95.4 M and net result halved to EUR 13.3 M; Floridienne cited unfavourable foreign exchange. In H1 2025 the division's turnover was EUR 259.5 M (up 9.8%) with a net result of EUR -4.4 M against EUR 6.8 M a year earlier. None of this isolates the US beneficials business.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Revenue by Segment

MetricFY2021FY2022FY2023FY2024FY2025

Life Sciences Division turnover (EUR Mn)

192337.1359.4507.1538.3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Results by Segment and Segment Margins & Growth (%)

MetricFY2022FY2023FY2024FY2025

Life Sciences Division EBITDA (EUR Mn)

47.841.2102.395.4

Life Sciences Division net result (EUR Mn)

13.38.127.713.3

Life Sciences EBITDA margin (%)

14.211.520.217.7

Life Sciences turnover growth (%)

75.56.641.16.2

Key Financials and Margin Analysis (%)

MetricFY2023FY2024FY2025

Floridienne group turnover (EUR Mn)

549.3697.4725.9

Life Sciences Division turnover (EUR Mn)

359.4507.1538.3

Life Sciences share of group turnover (%)

65.472.774.2

Revenue by Region

RegionFY2021FY2022FY2023FY2024FY2025

Americas (EUR Mn)

70.52205274343362

Revenue by Region (FY2024–FY2025)

RegionFY2024FY2025

Europe excluding Belgium (EUR Mn)

241247

Belgium (EUR Mn)

79.9681.64

Analyst Conclusions

Management guidance and consensus expectations do not exist for the company. Floridienne described the Life Sciences outlook as favourable in its FY2024 release.

Bull case

  1. Local production of perishable biologicals is a durable advantage, and the group has reinforced it rather than dismantled it.

  2. Group additions (BioWorks, Ecoation tools, Plant Products reach) widen what US customers can buy alongside beneficials.

  3. Structural demand for non-chemical pest control supports volume growth.

Bear case

  1. Parent profitability weakened in FY2025 and H1 2025, which may constrain capital for US capacity.

  2. Internal overlap could lead to brand consolidation and channel conflict.

  3. Zero financial transparency means deterioration would not be visible externally.

Monitorables for the next 12 months: Floridienne FY2026 results (expected around end March 2027), any change in Beneficial Insectary leadership or branding, US rollout of Plant Products, capacity announcements in Redding, and further North American deals by BioFirst.

Analyst verdict. Beneficial Insectary is a credible, long-established operating business, but it is not an investable public company and should not be analysed as one. It is a small production subsidiary several layers below a Brussels-listed holding company, and every hard number about its own performance is undisclosed. What can be said with confidence is qualitative. It owns a meaningful US rearing base, a catalog of about 30 biocontrol products, a heritage fly parasite franchise and a captive Northeast distributor. Its parent paid to acquire it in 2020, kept its management and brand, and has since invested heavily in adjacent North American assets, which suggests the US beneficials platform is regarded as strategic. The evidence gaps are large. Revenue, margins, headcount, capacity and customer concentration are unknown, and company-specific news has been thin since 2023. Parent-level data show a division that grew quickly through acquisition and then saw earnings soften in 2025, but nothing links that trend to Redding specifically. For commercial due diligence, partnership screening or competitor mapping, the right next step is primary research: distributor and grower interviews, California Secretary of State records, and a direct information request to BioFirst.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameRoleNotesSource

Cliff Noorlander

CEO, Beneficial Insectary

—

Press releases

Jim McCanlies

Sales Director USA

Joined July 2024; leads US sales, technical and marketing team

Hortibiz

Casey Decker

Managing Director, Sierra Biological

Continued to lead after 2023 acquisition

Greenhouse Grower

Cody Seals

Staff member, role not stated

Speaker at January 2024 workshop

CB Insights excerpt

Sinthya Penn

Former owner (1986 to 2020)

Sold all shares to Biobest

2020 release

Jean-Marc Vandoorne

CEO, BioFirst Group

Named as group CEO through August 2025

BioFirst releases

Gaëtan Waucquez

CEO, Floridienne S.A.

Parent executive

MarketScreener

Competitive Landscape

Key Competitors

CompetitorBasePositioning

Koppert

Netherlands

Global leader in beneficials and pollination; US operations

Bioline AgroSciences

UK / France

Beneficial insects and mites; US production

BioBee

Israel

Predatory mites, pollination; US subsidiary

Applied Bio-nomics

Canada

Canadian insectary

Anatis Bioprotection

Canada

Trichogramma and predators

Rincon-Vitova Insectaries

California

Long-established insectary and supplier

Arbico Organics

Arizona

Fly parasites and retail biocontrol

Evergreen Growers Supply

Oregon

Distributor of beneficials

BASF (Nemasys)

Germany

Nematodes

Biobest USA (sister company)

Group

Internal overlap in channels

Recent Developments

Company-specific news in the window from April 2025 to October 2026 was not found; the company blog shows no posts after January 2023. Group items and the most recent earlier company items are listed.

Company Snapshot

$663M

Market Cap

1986

Founded

CA, US

Headquarters

SWOT Analysis

Strengths

  • US-based production in Redding, cited by Biobest as giving an "unrivalled" North American production base with Canada and Mexico.
  • Catalog of about 30 named products covering aphids, mites, whitefly, thrips, mealybugs, caterpillars, soil pests and flies.
  • Decades of operating history under one owner (1986 to 2020).
  • Owned Northeast channel through Sierra Biological.
  • Access to Biobest R&D and a parent division with EUR 538.3 M turnover (FY2025).
  • Management continuity: the same CEO before and after the 2020 sale.

Weaknesses

  • No financial disclosure, which limits counterparty assessment.
  • Public communications are sparse; the last company blog post is from January 2023.
  • Reliance on distributors for market access.
  • Single disclosed production site in a wildfire-prone region of Northern California (analyst observation).
  • Overlap with Biobest USA and Plant Products inside the same group.

Opportunities

  • Cannabis segment, using Sierra technologies.
  • Cross-selling BioWorks biopesticides and Biobest digital scouting tools.
  • Wider US reach as Plant Products distribution expands (April 2026).
  • Livestock fly control heritage as a differentiated niche.

Threats

  • Parent margin pressure in FY2025 (EBITDA down from EUR 102.3 M to EUR 95.4 M) could tighten investment.
  • Possible brand consolidation into Biobest, despite stated autonomy.
  • Well-resourced global competitors with US production.
  • Biological production failures and shipping disruption, inherent to live products.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
31 Mar 2026Floridienne FY2025 results: Life Sciences turnover EUR 538.3 M, EBITDA EUR 95.4 MGrowth with margin pressure at parent
2 Apr 2026Biobest extends Plant Products distribution across the United States–
30 Sep 2025Floridienne H1 2025: Life Sciences turnover EUR 259.5 M, net result EUR -4.4 MWeaker first-half profitability
Aug 2025Biobest acquires Ecoation technologyDigital scouting tools for the group
31 Mar 2025Floridienne FY2024 record resultsBiotrop integration
Jul 2024Jim McCanlies named Sales Director USA (outside window)Commercial leadership
Apr 2024BioFirst Group rebrand (outside window)New group structure

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Revenue by Segment: Life Sciences Division turnover rose from EUR 192 Mn in FY2021 to EUR 538.3 Mn in FY2025.
Beneficial Insectary Inc. — Revenue by Segment
Series (EUR Mn)FY2021FY2022FY2023FY2024FY2025
Life Sciences Division turnover192337.1359.4507.1538.3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.